Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1996 Sep;165(3):144–147.

Propylthiouracil-induced hepatotoxicity.

J T Hardee 1, A L Barnett 1, A Thannoun 1, B Eghtesad 1, D Wheeler 1, M M Jamal 1
PMCID: PMC1303726  PMID: 8909171

Full text

PDF
146

Images in this article

145Figure 1.
on p.145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksoy M., Erdem S. Aplastic anaemia after propylthiouracil. Lancet. 1968 Jun 22;1(7556):1379–1379. doi: 10.1016/s0140-6736(68)92089-8. [DOI] [PubMed] [Google Scholar]
  2. Amrhein J. A., Kenny F. M., Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr. 1970 Jan;76(1):54–63. doi: 10.1016/s0022-3476(70)80130-5. [DOI] [PubMed] [Google Scholar]
  3. Baker B., Shapiro B., Fig L. M., Woodbury D., Sisson J. C., Beierwaltes W. H. Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology. 1989 Apr;1(1):17–26. [PubMed] [Google Scholar]
  4. Bilezikian S. B., Laleli Y., Tsan M. F., Hodkinson B. A., Ice S., McIntyre P. A. Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs. Johns Hopkins Med J. 1976 Apr;138(4):124–129. [PubMed] [Google Scholar]
  5. Bloch C. A., Jenski L. J., Balistreri W. F., Dolan L. M. Propylthiouracil-associated hepatitis. Arch Intern Med. 1985 Nov;145(11):2129–2130. [PubMed] [Google Scholar]
  6. Breese T. J., Solomon I. L. Granulocytopenia and hemolytic anemia as complications of propylthiouracil therapy. J Pediatr. 1975 Jan;86(1):117–119. doi: 10.1016/s0022-3476(75)80721-9. [DOI] [PubMed] [Google Scholar]
  7. COLWELL A. R., Jr, SANDO D. E., LANG S. J. Propylthiouracil-induced agranulocytosis, toxic hepatitis, and death. J Am Med Assoc. 1952 Feb 23;148(8):639–641. doi: 10.1001/jama.1952.62930080001013. [DOI] [PubMed] [Google Scholar]
  8. Czaja A. J. Autoimmune hepatitis and viral infection. Gastroenterol Clin North Am. 1994 Sep;23(3):547–566. [PubMed] [Google Scholar]
  9. EISEN M. J. Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med. 1953 Nov 12;249(20):814–816. doi: 10.1056/NEJM195311122492007. [DOI] [PubMed] [Google Scholar]
  10. Fedotin M. S., Lefer L. G. Liver disease caused by propylthiouracil. Arch Intern Med. 1975 Feb;135(2):319–321. [PubMed] [Google Scholar]
  11. Garty B. Z., Kauli R., Ben-Ari J., Lubin E., Nitzan M., Laron Z. Hepatitis associated with propylthiouracil treatment. Drug Intell Clin Pharm. 1985 Oct;19(10):740–742. doi: 10.1177/106002808501901009. [DOI] [PubMed] [Google Scholar]
  12. Hanson J. S. Propylthiouracil and hepatitis. Two cases and a review of the literature. Arch Intern Med. 1984 May;144(5):994–996. doi: 10.1001/archinte.144.5.994. [DOI] [PubMed] [Google Scholar]
  13. Hayashida C. Y., Duarte A. J., Sato A. E., Yamashiro-Kanashiro E. H. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest. 1990 Dec;13(11):937–941. doi: 10.1007/BF03349663. [DOI] [PubMed] [Google Scholar]
  14. Jonas M. M., Eidson M. S. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr. 1988 Sep-Oct;7(5):776–779. [PubMed] [Google Scholar]
  15. Kirkland J. L. Propylthiouracil-induced hepatic failure and encephalopathy in a child. DICP. 1990 May;24(5):470–471. doi: 10.1177/106002809002400505. [DOI] [PubMed] [Google Scholar]
  16. Lee W. M. Drug-induced hepatotoxicity. N Engl J Med. 1995 Oct 26;333(17):1118–1127. doi: 10.1056/NEJM199510263331706. [DOI] [PubMed] [Google Scholar]
  17. Liaw Y. F., Huang M. J., Fan K. D., Li K. L., Wu S. S., Chen T. J. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med. 1993 Mar 15;118(6):424–428. doi: 10.7326/0003-4819-118-6-199303150-00005. [DOI] [PubMed] [Google Scholar]
  18. Limaye A., Ruffolo P. R. Propylthiouracil-induced fatal hepatic necrosis. Am J Gastroenterol. 1987 Feb;82(2):152–154. [PubMed] [Google Scholar]
  19. MOVITT E. R., GERSTL B., DAVIS A. E. Needle liver biopsy in thyrotoxicosis. AMA Arch Intern Med. 1953 Jun;91(6):729–739. doi: 10.1001/archinte.1953.00240180038005. [DOI] [PubMed] [Google Scholar]
  20. Maddrey W. C., Boitnott J. K. Drug-induced chronic liver disease. Gastroenterology. 1977 Jun;72(6):1348–1353. [PubMed] [Google Scholar]
  21. Maggiore G., Larizza D., Lorini R., De Giacomo C., Scotta M. S., Severi F. Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl. J Pediatr Gastroenterol Nutr. 1989 May;8(4):547–548. doi: 10.1097/00005176-198905000-00025. [DOI] [PubMed] [Google Scholar]
  22. Mihas A. A., Holley P., Koff R. S., Hirschowitz B. I. Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology. 1976 May;70(5 PT1):770–774. [PubMed] [Google Scholar]
  23. Pacini F., Sridama V., Refetoff S. Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization. J Endocrinol Invest. 1982 Nov-Dec;5(6):403–407. doi: 10.1007/BF03350541. [DOI] [PubMed] [Google Scholar]
  24. Parker L. N. Letter: Hepatitis and propylthiouracil. Ann Intern Med. 1975 Feb;82(2):228–229. doi: 10.7326/0003-4819-82-2-228_2. [DOI] [PubMed] [Google Scholar]
  25. Parker W. A. Propylthiouracil-induced hepatotoxicity. Clin Pharm. 1982 Sep-Oct;1(5):471–474. [PubMed] [Google Scholar]
  26. Peter S. A. Propylthiouracil-associated hepatitis. J Natl Med Assoc. 1991 Jan;83(1):75–77. [PMC free article] [PubMed] [Google Scholar]
  27. Reddy C. M. Propylthiouracil and hepatitis: a case report. J Natl Med Assoc. 1979 Dec;71(12):1185–1186. [PMC free article] [PubMed] [Google Scholar]
  28. Safani M. M., Tatro D. S., Rudd P. Fatal propylthiouracil-induced hepatitis. Arch Intern Med. 1982 Apr;142(4):838–839. [PubMed] [Google Scholar]
  29. Sammon T. J., Peden V. H., Witzleben C., King J. P. Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year-old girl. Clin Pediatr (Phila) 1971 Dec;10(12):739–742. doi: 10.1177/000992287101001221. [DOI] [PubMed] [Google Scholar]
  30. Seidman D. S., Livni E., Ilie B., Blum I. Propylthiouracil-induced cholestatic jaundice. J Toxicol Clin Toxicol. 1986;24(4):353–360. doi: 10.3109/15563658608992599. [DOI] [PubMed] [Google Scholar]
  31. Shiran A., Shechner C., Dickstein G. Propylthiouracil-induced agranulocytosis in four patients previously treated with the drug. JAMA. 1991 Dec 11;266(22):3129–3130. [PubMed] [Google Scholar]
  32. Vasily D. B., Tyler W. B. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. JAMA. 1980 Feb 1;243(5):458–461. doi: 10.1001/jama.243.5.458. [DOI] [PubMed] [Google Scholar]
  33. Verdy M., Pretty H., Cadotte M., Giroux J. M., Journet M. Vasculite secondaire aux antithyroïdiens. Union Med Can. 1975 Apr;104(4):576–579. [PubMed] [Google Scholar]
  34. Vitug A. C., Goldman J. M. Hepatotoxicity from antithyroid drugs. Horm Res. 1985;21(4):229–234. doi: 10.1159/000180054. [DOI] [PubMed] [Google Scholar]
  35. Weiss M., Hassin D., Bank H. Propylthiouracil-induced hepatic damage. Arch Intern Med. 1980 Sep;140(9):1184–1185. [PubMed] [Google Scholar]
  36. Westphal S. A. Hepatotoxicity from propylthiouracil. South Med J. 1994 Sep;87(9):943–947. doi: 10.1097/00007611-199409000-00018. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES